共 106 条
- [1] Jemal A(2010)Cancer statistics, 2010 CA Cancer J Clin 60 277-300
- [2] Siegel R(2012)Prostate-cancer mortality at 11 years of follow-up N Engl J Med 366 981-90
- [3] Xu J(2002)Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends J Natl Cancer Inst 94 981-90
- [4] Ward E(2009)Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context J Natl Cancer Inst 101 374-83
- [5] Schröder FH(2005)Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower JAMA 294 66-70
- [6] Hugosson J(2009)Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer J Clin Oncol 27 398-403
- [7] Roobol MJ(2016)4-Kallikrein test and Kallikrein markers in prostate cancer screening Urol Clin North Am 43 39-46
- [8] Etzioni R(2016)Detection of high-grade prostate cancer using a urinary molecular biomarker-based risk score Eur Urol 70 740-8
- [9] Penson DF(2015)Evaluation of the PI-RADS scoring system for mpMRI of the prostate: a whole-mount step-section analysis World J Urol 33 1023-30
- [10] Legler JM(2016)Prostate cancer: PI-RADS version 2 helps preoperatively predict clinically significant cancers Radiology 280 108-16